Sacutan Tablet 49 mg + 51 mg combines Sacubitril and Valsartan, an advanced dual-acting therapy used for the management of heart failure with reduced ejection fraction (HFrEF). Sacubitril is a neprilysin inhibitor that increases levels of natriuretic peptides, promoting vasodilation, reducing sodium retention, and preventing harmful cardiac remodeling. Valsartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and reduces the workload on the heart.

This combination, known as an angiotensin receptor-neprilysin inhibitor (ARNI), addresses both neurohormonal and hemodynamic pathways involved in heart failure. Sacutan Tablet 49 mg + 51 mg is typically used as a maintenance dose for patients who have tolerated the initial lower dose (24 mg + 26 mg) and require ongoing therapy to optimize heart function and prevent recurrent heart failure episodes.

The medication helps improve cardiac output, reduce symptoms such as fatigue and shortness of breath, and lower the risk of hospitalization and cardiovascular-related death. Sacutan is administered orally and is suitable for long-term use under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Benefits

• Manages Heart Failure Symptoms: Reduces shortness of breath, swelling, and fatigue associated with chronic heart failure.

• Enhances Cardiac Function: Supports efficient heart pumping and prevents structural heart damage.

• Reduces Hospitalization Risk: Decreases the likelihood of heart failure-related admissions.

• Cardiovascular Protection: Lowers the risk of cardiovascular death in patients with HFrEF.

• Dual Mechanism of Action: Combines neprilysin inhibition and ARB therapy for superior heart failure management.

Indications

Sacutan Tablet 49 mg + 51 mg is prescribed for:

• Chronic heart failure with reduced ejection fraction (HFrEF)

• Maintenance therapy for patients stabilized on a lower starting dose

• Prevention of recurrent heart failure hospitalizations

• Symptomatic patients requiring optimized ARNI therapy

It is especially useful for patients who have successfully tolerated the initial therapy and need sustained control of heart failure symptoms.

Dosage and Administration

The usual maintenance dose is one tablet orally twice daily, with or without food, as directed by a healthcare professional.

• Swallow the tablet whole; do not crush or chew.

• Take at the same time each day to maintain stable drug levels.

• Regular monitoring of blood pressure, kidney function, and electrolytes is recommended during therapy.

Dose adjustments may be required for patients with kidney impairment, low blood pressure, or other comorbidities.

Possible Side Effects

Sacutan Tablet 49 mg + 51 mg is generally well tolerated. Common side effects may include:

• Low blood pressure (hypotension)

• Dizziness or lightheadedness

• Cough

• Elevated potassium levels (hyperkalemia)

• Changes in kidney function

Serious side effects, though rare, may include severe hypotension, angioedema, or kidney injury. Immediate medical attention is necessary if severe reactions occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Avoid concurrent use with ACE inhibitors to reduce the risk of angioedema.

• Inform your doctor if you have kidney disease, liver dysfunction, low blood pressure, or high potassium levels.

• Pregnant or breastfeeding women should not use this medication.

• Disclose all other medications to your healthcare provider to prevent interactions.

Storage

Store Sacutan Tablet 49 mg + 51 mg in a cool, dry place away from sunlight and moisture. Keep out of reach of children.